Histamine in allergic rhinitis

Advances in Experimental Medicine and Biology

Volumn 709, Issue , 2010, Pages 33-41

  Taylor Clark, Thomas ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA METHYLHISTAMINE; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CLOBENPROPIT; DESLORATADINE; DIMAPRIT; DIMETINDENE; DIPHENHYDRAMINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; HYDROXYZINE; LEVOCABASTINE; OLOPATADINE; TERFENADINE; THIOPERAMIDE;

ALLERGIC REACTION; ARTICLE; COUGHING; DERMATOPHAGOIDES; DRUG EFFICACY; HAY FEVER; HUMAN; IMMUNOMODULATION; MAST CELL DEGRANULATION; NONHUMAN; NOSE MUCOSA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; RHINORRHEA; SENSORY NERVE; SNEEZING;

EID: 79960709091     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8056-4_4     Document Type: Article

References (83)

1. Skoner DP. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection and diagnosis. Journal of Allergy and Clinical Immunology 2001; 108:S2-S8.
2. Morice AH. Epidemiology of cough. In: Chung F, Widdicombe J, Boushey HA, eds. Cough: Causes, Mechanisms and Therapy: Blackwell 2003:11-6.
3. Bolser DC. Older-generation antihistamines and cough due to upper airway cough syndrome (UACS): Efficacy and mechanism. Lung 2008; 186(Suppl 1):S74-7. (Pubitemid 351327287)
4. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990; 86:924-35.
5. Austin CE, Foreman JC. Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol 1994; 37:33-7. (Pubitemid 24204578)
6. Taylor-Clark T, Foreman J. Histamine-mediated mechanisms in the human nasal airway. Curr Opin Pharmacol 2005; 5:214-20. (Pubitemid 40674241)
7. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol 2004; 113:552-7. (Pubitemid 38902552)
8. Shelton D, Eiser N. Histamine receptors in the human nose. Clin Otolaryngol Allied Sci 1994; 19:45-9. (Pubitemid 24081614)
9. Secher C, Kirkegaard J, Borum P et al. Significance of H1 and H2 receptors in the human nose: Rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol 1982; 70:211-8. (Pubitemid 12028769)
10. Kirkegaard J, Secher C, Borum P et al. Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: Demonstration of topical effect. Br J Dis Chest 1983; 77:113-22. (Pubitemid 13117363)
11. Hilberg O, Grymer LF, Pedersen OF. Nasal histamine challenge in nonallergic and allergic subjects evaluated by acoustic rhinometry. Allergy 1995; 50:166-73.
12. Wood-Baker R, Lau L, Howarth PH. Histamine and the nasal vasculature: The influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci 1996; 21:348-52. (Pubitemid 26320845)
13. Wang DY, Hanotte F, De Vos C et al. Effect of cetirizine, levocetirizine and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy 2001; 56:339-43. (Pubitemid 32222616)
14. Mygind N, Secher C, Kirkegaard J. Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl 1983; 128(Pt 1):16-20. (Pubitemid 13035760)
15. Canning BJ. Neurology of allergic inflammation and rhinitis. Curr Allergy Asthma Rep 2002; 2:210-5.
16. Taylor-Clark TE, Kollarik M, MacGlashan DW, Jr, et al. Nasal sensory nerve populations responding to histamine and capsaicin. J Allergy Clin Immunol 2005; 116:1282-8. (Pubitemid 41740938)
17. Damann N, Rothermel M, Klupp BG et al. Chemosensory properties of murine nasal and cutaneous trigeminal neurons identified by viral tracing. BMC Neurosci 2006; 7:46.
18. Taylor-Clark TE, Kiros F, Carr MJ et al. Transient Receptor Potential Ankyrin 1 Mediates Toluene Diisocyanate-Evoked Respiratory Irritation. Am J Respir Cell Mol Biol 2008.
19. Asakura K, Narita S, Kojima T et al. Changes in nasal airway resistance and secretory response in the guinea pig after nasal challenge with capsaicin and histamine. Eur Arch Otorhinolaryngol 1994; 251:224-8. (Pubitemid 24213558)
20. Asakura K, Narita S, Kojima T et al. Role of capsaicin-sensitive sensory nerve reflexes in guinea pig model of nasal allergy. Int Arch Allergy Immunol 1993; 102:195-9. (Pubitemid 23285377)
21. Blom HM, Van Rijswijk JB, Garrelds IM et al. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997; 27:796-801. (Pubitemid 27306159)
22. Van Rijswijk JB, Boeke EL, Keizer JM et al. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: A double-blind randomized application regimen study. Allergy 2003; 58:754-61. (Pubitemid 36920465)
23. Mullol J, Raphael GD, Lundgren JD et al. Comparison of human nasal mucosal secretion in vivo and in vitro. J Allergy Clin Immunol 1992; 89:584-92.
24. Naclerio RM, Baroody FM. Response of nasal mucosa to histamine or methacholine challenge: Use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol 1992; 90:1051-4. (Pubitemid 23001382)
25. Baroody FM, Wagenmann M, Naclerio RM. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol 1993; 74:2661-71. (Pubitemid 23201289)
26. Holmberg K, Pipkorn U, Bake B et al. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis. Allergy 1989; 44:281-7. (Pubitemid 19130640)
27. Wang D, Clement P, Smitz J. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol 1996; 116:91-6. (Pubitemid 26040045)
28. Philip G, Baroody FM, Proud D et al. The human nasal response to capsaicin. J Allergy Clin Immunol 1994; 94:1035-45. (Pubitemid 124006618)
29. Plevkova J, Brozmanova M, Pecova R et al. The effects of nasal histamine challenge on cough reflex in healthy volunteers. Pulm Pharmacol Ther 2006; 19:120-7. (Pubitemid 43053000)
30. Havas TE, Cole P, Parker L et al. The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation. J Allergy Clin Immunol 1986; 78:856-60. (Pubitemid 17194637)
31. Taylor-Clark T, Sodha R, Warner B et al. Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol 2005.
32. Ishibe T, Kubo N, Kumazawa H et al. Histamine H1 receptors and affinity analyses in human nasal mucosa in cases of nasal allergy. Ann Otol Rhinol Laryngol 1985; 94:186-90. (Pubitemid 15096795)
33. Ikeda H, Kubo N, Nakamura A et al. Histamine-induced calcium released from cultured human mucosal microvascular endothelial cells from nasal inferior turbinate. Acta Otolaryngol 1997; 117:864-70. (Pubitemid 27521366)
34. Ortiz JL, Labat C, Norel X et al. Histamine receptors on human isolated pulmonary arterial muscle preparations: Effects of endothelial cell removal and nitric oxide inhibitors. J Pharmacol Exp Ther 1992; 260:762-7.
35. Dear JW, Ghali S, Foreman JC. Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase. Br J Pharmacol 1996; 118:1177-82. (Pubitemid 26235616)
36. McLean JA, Bacon JR, Mathews KP et al. Effects of aspirin on nasal responses in atopic subjects. J Allergy Clin Immunol 1983; 72:187-92. (Pubitemid 13044871)
37. Hore I, Georgalas C, Scadding G. Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis-a systematic review of randomized controlled trials. Clin Exp Allergy 2005; 35:207-12. (Pubitemid 40353784)
38. Gillard M, Christophe B, Wels B et al. H1 antagonists: Receptor affinity versus selectivity. Inflamm Res 2003; 52(Suppl 1):S49-50. (Pubitemid 36470055)
39. Iriyoshi N, Takeuchi K, Yuta A et al. Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 1996; 26:379-85. (Pubitemid 26122838)
40. Chang JY, Hardebo JE, Owman C. Differential vasomotor action of noradrenaline, serotonin and histamine in isolated basilar artery from rat and guinea-pig. Acta Physiol Scand 1988; 132:91-102.
41. Juliusson S, Bende M. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction. Rhinology 1996; 34:24-7.
42. Varty LM, Gustafson E, Laverty M et al. Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 2004; 484:83-9. (Pubitemid 38068537)
43. Varty LM, Hey JA. Histamine H3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa. Eur J Pharmacol 2002; 452:339-45. (Pubitemid 35279437)
44. Johannssen V, Maune S, Werner JA et al. Alpha 1-receptors at precapillary resistance vessels of the human nasal mucosa. Rhinology 1997; 35:161-5. (Pubitemid 28109331)
45. Malm L, Okuda M, Dieges PH. Direct and reflex actions of biochemical mediators. In: Allergic and Vasomotor Rhinitis: Pathophysiological Aspects 1987:214-9.
46. Lacroix JS, Stjarne P, Anggard A et al. Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 1988; 133:183-97.
47. McLeod RL, Mingo GG, Herczku C et al. Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion. Am J Rhinol 1999; 13:391-9.
48. Sanico AM, Philip G, Proud D et al. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: Effects of capsaicin nasal challenge. Clin Exp Allergy 1998; 28:92-100. (Pubitemid 28053932)
49. Nakaya M, Fukushima Y, Takeuchi N et al. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis. Laryngoscope 2005; 115:1778-84. (Pubitemid 41475888)
50. Yokota E, Kuyama S, Ogawa M et al. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice. Int Immunopharmacol 2008; 8:1083-8.
51. Yokota E, Kuyama S, Sugimoto Y et al. Participation of histamine H3 receptors in experimental allergic rhinitis of mice. J Pharmacol Sci 2008; 108:206-11.
52. Devillier P, Dessanges JF, Rakotosihanaka F et al. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. Eur Respir J 1988; 1:356-61.
53. Braunstein G, Fajac I, Lacronique J et al. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 1991; 144:630-5.
54. Rajakulasingam K, Polosa R, Lau LC et al. Nasal effects of bradykinin and capsaicin: Influence on plasma protein leakage and role of sensory neurons. J Appl Physiol 1992; 72:1418-24.
55. Sanico AM, Atsuta S, Proud D et al. Dose-dependent effects of capsaicin nasal challenge: In vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997; 100:632-41. (Pubitemid 27505849)
56. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006; 533:69-76. (Pubitemid 43340005)
57. Schneider E, Rolli-Derkinderen M, Arock M et al. Trends in histamine research: New functions during immune responses and hematopoiesis. Trends Immunol 2002; 23:255-63. (Pubitemid 34499563)
58. Fadel R, David B, Rassemont R et al. Eosinophil infiltration: Effects of H1 antihistamines. J Am Acad Dermatol 1991; 24:1094-6.
59. Ciprandi G, Cirillo I, Vizzaccaro A et al. Desloratadine and levocetirizine improve nasal symptoms, airflow and allergic inflammation in patients with perennial allergic rhinitis: A pilot study. Int Immunopharmacol 2005; 5:1800-8. (Pubitemid 41586220)
60. Reinartz SM, Overbeek SE, Kleinjan A et al. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy 2005; 60:1301-7. (Pubitemid 41297527)
61. Mahmoud F, Arifhodzic N, Haines D et al. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis. J Pharmacol Sci 2008; 108:149-56.
62. Lee CF, Sun HL, Lu KH et al. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Pediatr Allergy Immunol 2008.
63. Mygind N. Nasal inflammation and anti-inflammatory treatment. Semantics or clinical reality. Rhinology 2001; 39:61-5. (Pubitemid 32633345)
64. Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol 2002; 17:101-39.
65. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov 2008; 7:41-53.
66. Horak F, Toth J, Jager S et al. Effects of H1-receptor antagonists on nasal obstruction in atopic patients. Allergy 1993; 48:226-9. (Pubitemid 23153639)
67. Howarth PH, Holgate ST. Comparative trial of two nonsedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax 1984; 39:668-72. (Pubitemid 14059515)
68. Wong L, Hendeles L, Weinberger M. Pharmacologic prophylaxis of allergic rhinitis: Relative efficacy of hydroxyzine and chlorpheniramine. J Allergy Clin Immunol 1981; 67:223-8. (Pubitemid 11153802)
69. Falliers CJ, Brandon ML, Buchman E et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991; 66:257-62.
70. DuBuske L. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1995; 74:345-54.
71. Korsgren M, Andersson M, Borga O et al. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis. Ann Allergy Asthma Immunol 2007; 98:316-21. (Pubitemid 46582121)
72. Wilson AM, Haggart K, Sims EJ et al. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy 2002; 32:1504-9. (Pubitemid 35278920)
73. Horak F, Stubner UP, Zieglmayer R et al. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002; 109:956-61. (Pubitemid 34634305)
74. Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001; 56:1077-80. (Pubitemid 33020649)
75. Raphael GD, Angello JT, Wu MM et al. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006; 96:606-14.
76. Meltzer EO, Jalowayski AA, Vogt K et al. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: Results of a single-center, placebo-controlled trial. Ann Allergy Asthma Immunol 2006; 96:363-8. (Pubitemid 43277178)
77. Pradalier A, Neukirch C, Dreyfus I et al. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy 2007; 62:1331-4. (Pubitemid 47537496)
78. Horak F, Unkauf M, Beckers C et al. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis. Arzneimittelforschung 2000; 50:1099-105. (Pubitemid 32003002)
79. Brooks CD, Nelson A, Parzyck R et al. Protective effect of hydroxyzine and phenylpropanolamine in the challenged allergic nose. Ann Allergy 1981; 47:316-9. (Pubitemid 12248427)
80. Corren J, Rachelefsky G, Spector S et al. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions. J Allergy Clin Immunol 1999; 103:574-80. (Pubitemid 29295560)
81. Pecoud A, Zuber P, Kolly M. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test. Int Arch Allergy Appl Immunol 1987; 82:541-3. (Pubitemid 17056139)
82. Pipkorn P, Costantini C, Reynolds C et al. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Ann Allergy Asthma Immunol 2008; 101:82-9. (Pubitemid 352000749)
83. Rokenes HK, Andersson B, Rundcrantz H. Effect of terfenadine and placebo on symptoms after nasal allergen provocation. Clin Allergy 1988; 18:63-9.